These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31821157)

  • 21. Glucose regulation and cognitive function after bariatric surgery.
    Galioto R; Alosco ML; Spitznagel MB; Strain G; Devlin M; Cohen R; Crosby RD; Mitchell JE; Gunstad J
    J Clin Exp Neuropsychol; 2015; 37(4):402-13. PubMed ID: 25875124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics influencing expected cognitive performance during hypoglycaemia in type 2 diabetes.
    Petersen JZ; Nilsson M; Rungby J; Miskowiak KW
    Psychoneuroendocrinology; 2019 Dec; 110():104431. PubMed ID: 31536941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes.
    Mussell M; Hewer W; Kulzer B; Bergis K; Rist F
    Diabet Med; 2004 Nov; 21(11):1253-6. PubMed ID: 15498095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous ketone salts do not improve cognitive responses after a high-intensity exercise protocol in healthy college-aged males.
    Waldman HS; Basham SA; Price FG; Smith JW; Chander H; Knight AC; Krings BM; McAllister MJ
    Appl Physiol Nutr Metab; 2018 Jul; 43(7):711-717. PubMed ID: 29451991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial.
    Gejl M; Gjedde A; Brock B; Møller A; van Duinkerken E; Haahr HL; Hansen CT; Chu PL; Stender-Petersen KL; Rungby J
    Diabetologia; 2018 Mar; 61(3):551-561. PubMed ID: 29188338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Acutely Increased Endogenous- and Exogenous Ketone Bodies on FGF21 Levels in Humans.
    Lauritzen ES; Svart MV; Voss T; Møller N; Bjerre M
    Endocr Res; 2021 Feb; 46(1):20-27. PubMed ID: 33074729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point of care blood ketone testing of diabetic patients in the emergency department.
    Bektas F; Eray O; Sari R; Akbas H
    Endocr Res; 2004 Aug; 30(3):395-402. PubMed ID: 15554356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes.
    Hewer W; Mussell M; Rist F; Kulzer B; Bergis K
    Gerontology; 2003; 49(2):86-92. PubMed ID: 12574669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals.
    Myette-Côté É; Neudorf H; Rafiei H; Clarke K; Little JP
    J Physiol; 2018 Apr; 596(8):1385-1395. PubMed ID: 29446830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adults.
    Sims Wright R; Levy SA; Katzel LI; Rosenberger WF; Manukyan Z; Whitfield KE; Waldstein SR
    J Clin Exp Neuropsychol; 2015; 37(1):49-60. PubMed ID: 25562529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes.
    Yu H; Li H; Liu X; Du X; Deng B
    Aging (Albany NY); 2020 Feb; 12(5):4193-4203. PubMed ID: 32112645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate.
    Fioretto P; Trevisan R; Velussi M; Cernigoi A; De Riva C; Bressan M; Doria A; Pauletto N; Angeli P; De Donà C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):331-8. PubMed ID: 3298305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of effects of hyperglycemia on the disposal of 3-hydroxybutyrate in insulin-dependent diabetic patients.
    Møller N; Jørgensen JO; Møller J; Orskov L; Pørksen N; Alberti KG; Schmitz O
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):629-32. PubMed ID: 2284887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
    Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
    Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo-controlled, double blind, cross-over pilot study.
    Melmer A; Kempf P; Lunger L; Pieber TR; Mader JK; Stettler C; Tilg H; Ebenbichler CF; Laimer M
    Diabetes Obes Metab; 2018 Nov; 20(11):2685-2689. PubMed ID: 29923299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study.
    Henry RR; Dandona P; Pettus J; Mudaliar S; Xu J; Hansen L
    Diabetes Obes Metab; 2017 Jun; 19(6):814-821. PubMed ID: 28098426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.